VGB3 (ECRPPDDGLC) is a circular peptide that reproduces a binding region of VEGFB that can bind to both VEGFR1 [79] and VEGFR2 [80], and it shows anti-angiogenic and anti-tumor activity in vitro [79,80]. Here, FLT1 is linked to neoplasm.